SUPN Supernus Pharmaceuticals Inc.
Health Care, filed as Supernus Pharmaceuticals, Inc. (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab
In 2026 Q3 Michael Krensavage added to Supernus Pharmaceuticals.
Who owns this now
Largest portfolio weights among holders, up to 5.7% (Michael Krensavage, Krensavage Asset Management). Not free-float ownership.
Who owns SUPN
Sorted by value, long equity only, as of 2026 Q3.
| History | |||||
|---|---|---|---|---|---|
| Michael Krensavage, Krensavage Asset Management | Add +24.9% | 350,681 | $15M | History | |
| Third Avenue Management | Small add +2.9% | 157,150 | $6.8M | History |
Insider trades
Open-market buys and sales by SUPN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $1.8M sold by 4 insiders outside a trading plan
- $8.4M sold by 4 insiders under 10b5-1 plans
-
Padmanabh P. Bhatt Sr. VP of IP, CSOPlanned sale$5.4M 107,250 shares at $50.24 86% of stakeTraded Mar 16–18 Filed Mar 18
-
Jack A. Khattar CEOPlanned sale$1.8M 35,000 shares at $50.37 3.5% of stakeTraded Mar 13 Filed Mar 16
-
Frederick M. Hudson DirectorSale$272K 5,369 shares at $50.61 8.2% of stakeTraded Mar 12 Filed Mar 16
-
William Todd Horich SVP, Commercial OperationsSale$484K 8,877 shares at $54.50 100% of stakeTraded Mar 9–10 Filed Mar 10
-
Frank Mottola SVP, Chief Tech. Ops. OfficerSale$87K 1,623 shares at $53.65 8.1% of stakeTraded Mar 9 Filed Mar 10
-
Georges Gemayel DirectorSale$1M 18,787 shares at $53.38 41% of stakeTraded Mar 5–6 Filed Mar 9
-
Bethany Sensenig DirectorPlanned sale$228K 4,475 shares at $51.01 100% of stakeTraded Feb 19 Filed Feb 23
-
Frank Mottola SVP, Chief Tech. Ops. OfficerPlanned sale$1M 20,000 shares at $50.41 56% of stakeTraded Dec 19, 2025 Filed Dec 22, 2025
-
Jack A. Khattar CEOPlanned sale$3M 59,900 shares at $50.57 4.7% of stakeTraded Oct 9, 2025 Filed Oct 10, 2025
-
Charles W. Newhall III DirectorPlanned sale$1.3M 25,000 shares at $50.77 19% of stakeTraded Oct 9, 2025 Filed Oct 10, 2025
Also filed in the last 12 months, not counted as buying or selling: 28 share withholdings for taxes, 27 option exercises, 20 stock grants, 12 other transactions, and 1 sale to cover taxes.
Congress
1 member of Congress traded SUPN in the last three years: 3 buys and 1 sale. 2 members listed it in 2025 annual reports.
-
Gilbert Ray Cisneros, Jr.
Buy
$1K–$15K
Mar 3
filed Apr 7
-
Gilbert Ray Cisneros, Jr.
Buy
$1K–$15K
Dec 11, 2025
filed Jan 12
-
Gilbert Ray Cisneros, Jr.
Partial sale
$1K–$15K
Oct 9, 2025
filed Nov 18, 2025
-
Gilbert Ray Cisneros, Jr.
Buy
$1K–$15K
Mar 24, 2025
filed Apr 7, 2025
SEC filings
Recent issuer filings from EDGAR, 18 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 3.01 | Filing Doc | |
| 8-K | 1.01,2.01,2.03,3.03,5.01,5.03,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.02,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 2.02 | Filing Doc | |
| 8-K | 5.07,9.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 1.01,5.02,8.01,9.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| DEFA14A | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
Balance sheet
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.
Further reading
As an Amazon Associate, FollowTheFilings earns from qualifying purchases.
- How to Read a Financial Report (Tracy & Tracy) View on Amazon
- Financial Statements QuickStudy Laminated Guide View on Amazon